Primary antibodies included (1) anti-CD3 (monoclonal mouse IgG2a, Biocarta, Hamburg, Germany) to mark mucosal T lymphocytes, (2) anti-IgA antibody (α-Heavy Chain) Ab-1 (monoclonal mouse IgG1κ ...

A novel mouse IgG2a monoclonal antibody targeting NPM1 (anti-NPM1) exerted anti-tumour activity and increased survival in several mouse models of AML, including patient-derived xenografts, without ...